EVALUATION COMPARISON BETWEEN SINOVAC AND PFIZER VACCINE AMONG INDONESIAN CHILDREN AND TEENAGER UNDER 18 YEARS OLD

4Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Objective: To evaluate the comparison between the Sinovac vaccine and Pfizer vaccine for children and teenagers under 18 y in Indonesia and other factors that influence it. Methods: The type of this research is observational with a cross-sectional design using convenience sampling for all children and teenager in Indonesia who has received the full dose of Sinovac and Pfizer vaccine. Results: It was found that the efficacy for Sinovac and Pfizer vaccines was 99.5% and 99.75%, respectively. Other factors that influence the side effects and efficacy of vaccines are gender, age, and BMI, with a p-value of each variable<0.05. Conclusion: There is a correlation between the type of vaccine, gender, age, and BMI with the efficacy and side effects of vaccination.

Cite

CITATION STYLE

APA

Sutardi, A. Q. I., & Ramatillah, D. L. (2022). EVALUATION COMPARISON BETWEEN SINOVAC AND PFIZER VACCINE AMONG INDONESIAN CHILDREN AND TEENAGER UNDER 18 YEARS OLD. International Journal of Applied Pharmaceutics, 14(Special issue 2), 22–30. https://doi.org/10.22159/ijap.2022.v14s2.44745

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free